Responsible use of pop culture and communication in the face of Ebola | U.N. Security Council adopts measure to identify chlorine bomb users in Syria | Emergent BioSolutions plans to spin-off biosciences company | Ebola survivor meeting explores research priorities, ‘biobanking’ | Rapid response kept Ohio botulism outbreak in check | New York cooling towers to be tested as Legionnaires’ deaths hit 10 | Outgoing HHMI chief reflects on leading $18 billion biomedical charity | What ‘100 percent effective’ means for that Ebola vaccine | U.S. health regulator issues new cleaning guide for superbug-prone device | CDC’s plan to reduce superbug infections is wishful thinking | Trial sheds light on lower VSV-EBOV doses | Ebola survivors face lingering pain, fatigue and depression | Polio vaccination programs face challenges in high-conflict areas | California child diagnosed with plague after Yosemite trip

See what we’re reading this week at Global Biodefense on topics including Legionnaires’ in New York, long-term health challenges for Ebola survivors, and plague in Yosemite.

Responsible use of pop culture and communication in the face of Ebola (PLOS)

U.N. Security Council adopts measure to identify chlorine bomb users in Syria (NY Times)

Emergent BioSolutions plans to spin-off biosciences company (Washington Post)

Ebola survivor meeting explores research priorities, ‘biobanking’ (CIDRAP)

Rapid response kept Ohio botulism outbreak in check (Food Safety News)

New York cooling towers to be tested as Legionnaires’ deaths hit 10 (Reuters)

Outgoing HHMI chief reflects on leading $18 billion biomedical charity (Science)

What ‘100 percent effective’ means for that Ebola vaccine (Wired)

U.S. health regulator issues new cleaning guide for superbug-prone device (Reuters)

CDC’s plan to reduce superbug infections is wishful thinking (Forbes)

Trial sheds light on lower VSV-EBOV doses (CIDRAP)

Ebola survivors face lingering pain, fatigue and depression (NY Times)